PL2559439T3 - Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego - Google Patents

Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego

Info

Publication number
PL2559439T3
PL2559439T3 PL12192951T PL12192951T PL2559439T3 PL 2559439 T3 PL2559439 T3 PL 2559439T3 PL 12192951 T PL12192951 T PL 12192951T PL 12192951 T PL12192951 T PL 12192951T PL 2559439 T3 PL2559439 T3 PL 2559439T3
Authority
PL
Poland
Prior art keywords
pharmaceutical preparation
benign prostatic
prostatic hyperplasia
treating benign
treating
Prior art date
Application number
PL12192951T
Other languages
English (en)
Inventor
Lucia Desser
Bernhard Lotz
Thomas Mohr
Original Assignee
Volopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Volopharm Gmbh filed Critical Volopharm Gmbh
Publication of PL2559439T3 publication Critical patent/PL2559439T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL12192951T 2007-12-03 2008-12-03 Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego PL2559439T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0196207A AT506095A1 (de) 2007-12-03 2007-12-03 Verwendung von proteasen
EP12192951.7A EP2559439B1 (en) 2007-12-03 2008-12-03 Pharmaceutical preparation for treating benign prostatic hyperplasia
EP08856631A EP2224948A1 (en) 2007-12-03 2008-12-03 Pharmaceutical preparation for treating benign prostatic hyperplasia

Publications (1)

Publication Number Publication Date
PL2559439T3 true PL2559439T3 (pl) 2015-04-30

Family

ID=40404976

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12192951T PL2559439T3 (pl) 2007-12-03 2008-12-03 Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego

Country Status (11)

Country Link
US (1) US8231870B2 (pl)
EP (2) EP2559439B1 (pl)
JP (1) JP2011505385A (pl)
AT (1) AT506095A1 (pl)
CA (1) CA2705986C (pl)
DK (1) DK2559439T3 (pl)
ES (1) ES2528348T3 (pl)
MX (1) MX2010005629A (pl)
PL (1) PL2559439T3 (pl)
RU (1) RU2485971C2 (pl)
WO (1) WO2009070818A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI482629B (zh) 2008-07-01 2015-05-01 Tobishi Pharmaceutical Co 下泌尿道疾病治療劑及下泌尿道症狀改善劑
EP2341925B1 (en) * 2008-09-10 2014-11-26 PT. Dexa Medica Thrombolytic/ anti thrombosis agent and its production method
JP6091431B2 (ja) * 2011-01-31 2017-03-15 ルコラス−エム．ディー．リミテッド 医薬的使用
AU2012253379A1 (en) 2011-05-12 2013-11-21 Healthpoint, Ltd. Wound debridement compositions containing seaprose and methods of wound treatment using same
MX2014013745A (es) * 2012-05-11 2016-05-05 Smith & Nephew Inc Uso de seaprose para eliminar la pelicula biologica bacteriana.
ITMI20121997A1 (it) * 2012-11-23 2014-05-24 Velleja Res Srl Composizioni fibrinolitiche per la prevenzione e il trattamento degli stati flebotrombotici
ITTO20121050A1 (it) * 2012-12-06 2014-06-07 Giuseppe Carpignoli Sostanze vegetali ad effetto curativo
US10086053B2 (en) 2012-12-06 2018-10-02 Giuseppe CARPIGNOLI Therapeutic vegetable substances
CA2926183C (en) * 2013-10-23 2018-07-03 Gemvax & Kael Co., Ltd. Composition for treating and preventing benign prostatic hyperplasia
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CA2959361A1 (en) * 2014-08-25 2016-03-03 Anatara Lifesciences Limited Anti-diarrhea formulation which avoids antimicrobial resistance
CA3031866A1 (en) 2016-07-27 2018-02-01 Smith & Nephew, Inc. Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces
IT201600081379A1 (it) * 2016-08-03 2018-02-03 Neilos S R L Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
WO2018140707A1 (en) 2017-01-30 2018-08-02 Smith & Nephew, Inc. Synergistic combination of thermolysin and an antibacterial agent to reduce eliminate bacterial biofilms from surfaces
JP7207877B2 (ja) * 2018-06-27 2023-01-18 小林製薬株式会社 ナットウキナーゼを含む食品
JP7207878B2 (ja) * 2018-06-27 2023-01-18 小林製薬株式会社 ナットウキナーゼを含む食品

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1003981A1 (en) * 1989-01-27 1998-11-13 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
JPH05229983A (ja) * 1992-02-21 1993-09-07 Sankyo Co Ltd レトロジヒドロカルコン化合物
DE4305460C2 (de) 1993-02-23 1997-09-04 Albert Dr Scheller Pharmazeutische oder kosmetische, Enzyme enthaltende Zubereitung, Verfahren zu deren Herstellung und deren Verwendung
JP3978250B2 (ja) * 1996-08-16 2007-09-19 株式会社フジモト・コーポレーション テストステロン５α−リダクターゼ阻害剤
US20010025059A1 (en) * 2000-01-10 2001-09-27 Kastke Floyd A. Composition and method for treating non-bacterial prostatitis
ZA200002342B (en) 2000-05-12 2001-01-11 Pharmachoice Healthcare Propri Nutritional supplement.
AU2002350623A1 (en) 2001-10-26 2003-05-06 The Scripps Research Institute Targeted thrombosis by tissue factor polypeptides
EP1553974A1 (en) * 2002-09-19 2005-07-20 Cristiano Alberto Ribeiro Santana Pharmaceutical composition comprising carriers for products
LV13161B (en) * 2004-02-16 2005-07-20 Maris Skromanis Proteolytic pharmaceutical composition
US20060024385A1 (en) 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
RU2306145C1 (ru) * 2006-03-28 2007-09-20 Олег Викторович Бейдик Средство для лечения хронического простатита

Also Published As

Publication number Publication date
JP2011505385A (ja) 2011-02-24
DK2559439T3 (en) 2014-12-08
WO2009070818A1 (en) 2009-06-11
EP2559439A1 (en) 2013-02-20
EP2559439B1 (en) 2014-11-26
US8231870B2 (en) 2012-07-31
CA2705986C (en) 2017-06-13
RU2010127336A (ru) 2012-01-10
EP2224948A1 (en) 2010-09-08
US20100254968A1 (en) 2010-10-07
AT506095A1 (de) 2009-06-15
CA2705986A1 (en) 2009-06-11
MX2010005629A (es) 2010-08-18
RU2485971C2 (ru) 2013-06-27
ES2528348T3 (es) 2015-02-09

Similar Documents

Publication Publication Date Title
PL2559439T3 (pl) Preparat farmaceutyczny do leczenia łagodnego rozrostu gruczołu krokowego
IL257681A (en) Methods and compositions for the treatment of cancer
EP2152722A4 (en) COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER
IL197389A0 (en) Prophylactic or therapeutic agent for cancer
SI2358697T1 (sl) Spojine izoindolina za uporabo pri zdravljenju raka
GB0807263D0 (en) Formulations for cancer treatment
HUE044220T2 (hu) Készítmények kollagén-közvetített betegségek kezelésére
SI2200431T1 (sl) Sestave in metode za zdravljenje raka
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
ZA201109513B (en) Composition for the treatment of benign prostate hyperplasia
EP2231185A4 (en) METHOD AND COMPOSITIONS FOR TREATING LIQUID TUMORS
IL196206A0 (en) Isoindoline derivatives for the treatment of arrhythmias
ZA201003425B (en) 5-cyano-thienopyridines for the treatment of tumors
EP2083840A4 (en) IMPROVED TREATMENT FOR BENEFICIAL PROSTATE HYPERPLASIA
ZA201007362B (en) Conjugates for the treatment of mesothelioma
PL2331092T3 (pl) Sposoby i kompozycje do podawania 3-halopirogronianiu i związków pochodnych w leczeniu nowotworu
EP2004205A4 (en) INORGANIC SELEN FOR THE TREATMENT OF GOOD TUMORS
IL226362A0 (en) compounds, and methods for treating cancer
EP2344528A4 (en) DRUGS AND FIBROSIS, ITS COMPOSITION AND USES
ZA200900076B (en) Isoindoline derivatives for the treatment of arrhythmias
AU2006905763A0 (en) Improved treatment for benign prostatic hyperplasia
GB0710871D0 (en) Cancer treatment
AU2006905835A0 (en) Treatment of benign prostatic hyperplasia
AU2006900091A0 (en) Treatment of begnign prostatic hyperplasia
GB0608007D0 (en) Preparation for the treatment of burns